198 related articles for article (PubMed ID: 24124473)
1. Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site.
Venghateri JB; Gupta TK; Verma PJ; Kunwar A; Panda D
PLoS One; 2013; 8(10):e75182. PubMed ID: 24124473
[TBL] [Abstract][Full Text] [Related]
2. An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.
Rai A; Surolia A; Panda D
PLoS One; 2012; 7(8):e44311. PubMed ID: 22952952
[TBL] [Abstract][Full Text] [Related]
3. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin.
Rashid A; Kuppa A; Kunwar A; Panda D
Biochemistry; 2015 Mar; 54(12):2149-59. PubMed ID: 25747795
[TBL] [Abstract][Full Text] [Related]
5. Crocin, a carotenoid, suppresses spindle microtubule dynamics and activates the mitotic checkpoint by binding to tubulin.
Sawant AV; Srivastava S; Prassanawar SS; Bhattacharyya B; Panda D
Biochem Pharmacol; 2019 May; 163():32-45. PubMed ID: 30710515
[TBL] [Abstract][Full Text] [Related]
6. Rhizoxin binding to tubulin at the maytansine-binding site.
Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y
Biochim Biophys Acta; 1987 Dec; 926(3):215-23. PubMed ID: 3120782
[TBL] [Abstract][Full Text] [Related]
7. The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.
Martin K; Müller P; Schreiner J; Prince SS; Lardinois D; Heinzelmann-Schwarz VA; Thommen DS; Zippelius A
Cancer Immunol Immunother; 2014 Sep; 63(9):925-38. PubMed ID: 24906866
[TBL] [Abstract][Full Text] [Related]
8. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding.
Srivastava P; Panda D
FEBS J; 2007 Sep; 274(18):4788-801. PubMed ID: 17697112
[TBL] [Abstract][Full Text] [Related]
9. Genistein arrests cell cycle progression of A549 cells at the G(2)/M phase and depolymerizes interphase microtubules through binding to a unique site of tubulin.
Mukherjee S; Acharya BR; Bhattacharyya B; Chakrabarti G
Biochemistry; 2010 Mar; 49(8):1702-12. PubMed ID: 20085293
[TBL] [Abstract][Full Text] [Related]
10. HMBA depolymerizes microtubules, activates mitotic checkpoints and induces mitotic block in MCF-7 cells by binding at the colchicine site in tubulin.
Chatterji BP; Banerjee M; Singh P; Panda D
Biochem Pharmacol; 2010 Jul; 80(1):50-61. PubMed ID: 20302847
[TBL] [Abstract][Full Text] [Related]
11. Antitubulin activities of ansamitocins and maytansinoids.
Ikeyama S; Takeuchi M
Biochem Pharmacol; 1981 Sep; 30(17):2421-5. PubMed ID: 21043240
[TBL] [Abstract][Full Text] [Related]
12. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin.
Bhattacharya S; Kumar NM; Ganguli A; Tantak MP; Kumar D; Chakrabarti G
PLoS One; 2013; 8(10):e76286. PubMed ID: 24116100
[TBL] [Abstract][Full Text] [Related]
13. A synthetic dolastatin 10 analogue suppresses microtubule dynamics, inhibits cell proliferation, and induces apoptotic cell death.
Gajula PK; Asthana J; Panda D; Chakraborty TK
J Med Chem; 2013 Mar; 56(6):2235-45. PubMed ID: 23445405
[TBL] [Abstract][Full Text] [Related]
14. Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules.
Lopus M; Oroudjev E; Wilson L; Wilhelm S; Widdison W; Chari R; Jordan MA
Mol Cancer Ther; 2010 Oct; 9(10):2689-99. PubMed ID: 20937594
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity.
Gupta K; Panda D
Biochemistry; 2002 Oct; 41(43):13029-38. PubMed ID: 12390030
[TBL] [Abstract][Full Text] [Related]
16. Cellular effects of leishmanial tubulin inhibitors on L. donovani.
Havens CG; Bryant N; Asher L; Lamoreaux L; Perfetto S; Brendle JJ; Werbovetz KA
Mol Biochem Parasitol; 2000 Oct; 110(2):223-36. PubMed ID: 11071278
[TBL] [Abstract][Full Text] [Related]
17. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
Mohan R; Panda D
Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
[TBL] [Abstract][Full Text] [Related]
18. Maytansine inhibits nucleotide binding at the exchangeable site of tubulin.
Huang AB; Lin CM; Hamel E
Biochem Biophys Res Commun; 1985 May; 128(3):1239-46. PubMed ID: 4004859
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of alpha-hydroxymethylated conjugated nitroalkenes for their anticancer activity: inhibition of cell proliferation by targeting microtubules.
Mohan R; Rastogi N; Namboothiri IN; Mobin SM; Panda D
Bioorg Med Chem; 2006 Dec; 14(23):8073-85. PubMed ID: 16891118
[TBL] [Abstract][Full Text] [Related]
20. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
